AFP and hepatocellular carcinoma: It was revealed that serum 3 anti-glycan markers plus AFP levels was a potential marker for discriminating HBV-positive HCC patients from healthy controls with an AUC (the areas under the ROC curve) of 0.6843 (95% CI: 0.5882–0.7805) (Figure 6A).